There is no LIMIT for ENZC stock price appreciation!!!
Too much going on with ENZC.
The company could drop press release any time that WILL send the stock past all previous HIGHS!
FACTS we KNOW:
1. AI
2. Monoclonal Antibodies being produced
3. Toxicity study results imminent
4. 19+ Patents
5. 2020 Annual Report imminent
6. PCOAB for 2019 and 2020 expected next month
7. The application for OTCQB is being prepared for submission upon issuance of the Audited Statements
8. Charles is in Charge
What we don't know:
1. Relationship to Gileads?
2. Relationship to Eli Lily?
3. Relationship to Immunome?
4. Acquisition?
ENZC has used AI to advance/expedite the production of Monoclonal Antibodies.
ENZC is still at the ground floor with the foundation set, the cornerstone in place and is building a solid company that will rival, challenge and change the landscape of the pharmaceutical world in a way that has never be seen before.
Enzolytics continues its onward and upward march towards strategic partnerships and a stronger Intellectual Property portfolio.
#ENZC #HIV #COVID19 #AI #Gileads #EliLilly #Patent #Monoclonal #Antibodies #acquisition #partnership #immunome
The Company is actively progressing to produce monoclonal antibodies against many other viruses. The proprietary methodically used by the Company will be employed to produce monoclonal antibodies against numerous other virus and using "AI", the Company is curating the know sequences of the following viruses and intends to both seek patent coverage and produce monoclonal antibodies targeting conserved sequences These viruses include:
HIV-2, Influenza A and B, H1N1 influenza, Respiratory syncytial virus (RSV), Small-Pox, Ebola Virus, Tetanus, Diphtheria, HTLV-1/2, Rabies, Herpes zoster, Varicella zoster, Anthrax, Mason-Pfizer monkey virus (MPMV) and Visna virus (VISNA). Patent applications will be filed claiming the inventive findings. Patent claims will cover the discovered epitope/antigens, with proposed vaccine claims, antibody claims, and related prophylactic/therapeutic method claims relating to these identified epitope/antigens.
